Company profile: Florida Pharma Products
1.1 - Company Overview
Company description
- Provider of generic prescription pharmaceuticals, covering development, sales, marketing, and distribution across therapeutic areas. Also provides R&D to identify new treatments, project management from R&D to commercialization, business development via licensing, acquisition, profit-sharing and development partnerships, plus operations to reduce costs and increase productivity.
Products and services
- Research and Development: Lifecycle-driven research invests in research to identify new treatments and guides product candidates through the development lifecycle
- Generic Pharmaceuticals: Multi-therapeutic portfolio develops, sells, markets, and distributes generic prescription medications across various therapeutic areas
- Sales and Marketing: Market-wide programs establish sales strategies and cover the market to acquire accounts and maximize purchasing behavior
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Florida Pharma Products
International Vitamin
HQ: United States
Website
- Description: Provider of private label vitamin and nutritional supplements for store brands across retail channels, offering manufacturing, distribution, and contract services for vitamins, minerals, supplements, OTC and prescription products. Capabilities include soft gels (including vegetarian) and continuous-process tablets with Nutraglide coating, supported by R&D and regulatory expertise.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full International Vitamin company profile →
Asymchem
HQ: China
Website
- Description: Provider of CDMO and pharmaceutical manufacturing services and biotech solutions, focused on R&D of pharmaceutical raw materials synthesis technology applied to drug development and production, supporting efficient, flexible processes and accelerating the commercial launch of biotech products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Asymchem company profile →
Remus Pharmaceuticals
HQ: United States
Website
- Description: Provider of sterile liquid injectables and oral solid forms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remus Pharmaceuticals company profile →
Ramarketing
HQ: United Kingdom
Website
- Description: Provider of marketing, advertising, public relations, SEO, content creation, graphic design, and consulting services for companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ramarketing company profile →
Aptus Clinical
HQ: United Kingdom
Website
- Description: Provider of specialist clinical contract research services, offering Catalyst Oncology, a clinical research organization focusing on oncology supporting biotech companies in developing cancer therapies, and Catalyst Flex, multi-therapeutic functional service provider solutions including clinical operations, data management, biostatistics, programming, safety, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptus Clinical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Florida Pharma Products
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Florida Pharma Products
2.2 - Growth funds investing in similar companies to Florida Pharma Products
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Florida Pharma Products
4.2 - Public trading comparable groups for Florida Pharma Products
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →